A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems
- PMID: 28663439
- DOI: 10.1126/science.aao0100
A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems
Abstract
Type III CRISPR-Cas systems in prokaryotes provide immunity against invading nucleic acids through the coordinated degradation of transcriptionally active DNA and its transcripts by the Csm effector complex. The Cas10 subunit of the complex contains an HD nuclease domain that is responsible for DNA degradation and two Palm domains with elusive functions. In addition, Csm6, a ribonuclease that is not part of the complex, is also required to provide full immunity. We show here that target RNA binding by the Csm effector complex of Streptococcus thermophilus triggers Cas10 to synthesize cyclic oligoadenylates (cA n ; n = 2 to 6) by means of the Palm domains. Acting as signaling molecules, cyclic oligoadenylates bind Csm6 to activate its nonspecific RNA degradation. This cyclic oligoadenylate-based signaling pathway coordinates different components of CRISPR-Cas to prevent phage infection and propagation.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Comment in
-
Microbiology: The case of the mysterious messenger.Nature. 2017 Aug 31;548(7669):527-528. doi: 10.1038/nature23532. Epub 2017 Aug 2. Nature. 2017. PMID: 28783729 No abstract available.
-
Intracellular signaling in CRISPR-Cas defense.Science. 2017 Aug 11;357(6351):550-551. doi: 10.1126/science.aao2210. Science. 2017. PMID: 28798118 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
